Catena AB
SE0001664707 Short position disclosed on April 24, 2026.
0.59% of the capital sold short
1 disclosing funds
9 disclosures on record
Funds holding Catena AB Titelia
Evolution of the disclosed total
0%0.5%1%1.5%
Oct 2025Jan 2026Apr 2026Jul 2026
January 8, 2025 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Arrowstreet Capital Limited Partnership | 0.59% | -0.11 pt | April 24, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| June 23, 2026 | Qube Research & Technologies Limited | 0.50% | still open |
| April 24, 2026 | Arrowstreet Capital Limited Partnership | 0.59% | still open |
| February 26, 2026 | Arrowstreet Capital Limited Partnership | 0.63% | still open |
| January 26, 2026 | Qube Research & Technologies Limited | 0.56% | still open |
| January 14, 2026 | Qube Research & Technologies Limited | 0.60% | still open |
| December 19, 2025 | Qube Research & Technologies Limited | 0.54% | still open |
| February 14, 2025 | Arrowstreet Capital Limited Partnership | 0.70% | still open |
| January 15, 2025 | Arrowstreet Capital Limited Partnership | 0.62% | still open |
| January 8, 2025 | Arrowstreet Capital Limited Partnership | 0.51% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.30% of the capital sold short
- Elekta AB (publ) 10.32% of the capital sold short
- JM AB 7.01% of the capital sold short
- Embracer Group AB 5.83% of the capital sold short
- Hemnet Group AB (publ) 5.59% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Bonesupport Holding AB 5.38% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.02% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Stillfront Group AB (publ) 3.87% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
- RaySearch Laboratories AB (publ) 3.63% of the capital sold short